Related Experiment Videos
Lipid patterns in haemodialysed and transplanted patients
Summary
Most dialysis and transplant patients have abnormal plasma lipid patterns, often hypertriglyceridemia. A low-carbohydrate, hypocaloric diet normalized lipids in transplanted patients, suggesting a dietary approach for managing dyslipidemia in renal disease.
Area of Science:
- Nephrology
- Cardiology
- Clinical Nutrition
Background:
- Abnormal plasma lipid patterns are prevalent in patients undergoing dialysis and renal transplantation.
- Dyslipidemia, particularly hypertriglyceridemia and hypercholesterolemia, is common in these patient populations.
- These lipid abnormalities are recognized risk factors for accelerated atherosclerosis.
Purpose of the Study:
- To investigate the plasma lipid patterns in dialysis and renal transplant patients.
- To evaluate the efficacy of a dietary intervention for managing severe hypertriglyceridemia in renal transplant recipients.
Main Methods:
- Plasma lipid profiles were analyzed in 103 dialysis patients and 66 renal transplant patients.
- A therapeutic trial involved a hypocaloric (1700 kcal) and low-carbohydrate (130 g) diet for 15 transplanted patients with severe hypertriglyceridemia.
- Lipid patterns were monitored during the dietary intervention period (3-12 months).
Main Results:
- A normal lipid pattern was observed in only 32% of dialysis patients and 30% of transplant patients.
- Hypertriglyceridemia was the most frequent lipid disorder, followed by hypercholesterolemia.
- The dietary intervention successfully normalized plasma lipid patterns in all 15 treated transplanted patients, with sustained normalization throughout the observation period.
Conclusions:
- Renal patients on dialysis or post-transplant frequently exhibit dyslipidemia, increasing atherosclerosis risk.
- A hypocaloric, low-carbohydrate diet is an effective therapeutic strategy for normalizing plasma lipids in renal transplant patients with severe hypertriglyceridemia.
- Dietary modification represents a viable approach to managing dyslipidemia in patients with chronic kidney disease and post-transplant status.